SCHEMBL2178177

SCHEMBL2178177

O=S(=O)(c1ccc(C(CC2CCCCC2)c2cc3ncc(Cl)nc3[nH]2)cc1)C1CC1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 19/20 0.47
LNPEP Q9UIQ6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178444 0.85 GCK (0.50) GCKLNPEP
SCHEMBL2178618 0.81 GCK (0.52) GCKLNPEP
SCHEMBL2196267 0.80 GCK (0.70) GCK
SCHEMBL2347451 0.79 GCK (0.71) GCK
SCHEMBL2195760 0.78 GCK (0.70) GCK
SCHEMBL2178179 0.78 ALDH1A1 (0.34) GCKLNPEP
SCHEMBL2197921 0.77 GCK (0.71) GCK
SCHEMBL2179861 0.77 GSR (0.37) GCK
SCHEMBL2179064 0.76 GCK (0.44) GCKLNPEP
SCHEMBL2178905 0.75 GCK (0.38) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011080755-A1 FUSED NITROGEN HETEROCYCLIC COMPOUNDS, PROCESS OF PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-07-07 WO disclosed